Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 54Lymphoma 49Leukemia 44Burkitt Lymphoma 39Lymphoma, Large B-Cell, Diffuse 37Lymphoma, Follicular 37Lymphoma, Non-Hodgkin 34Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Myeloid, Chronic-Phase 27Leukemia, Lymphocytic, Chronic, B-Cell 27Myelodysplastic Syndromes 26Leukemia, Myeloid, Acute 25Leukemia, Myeloid, Accelerated Phase 25Hodgkin Disease 22Lymphoma, Mantle-Cell 21Lymphoma, B-Cell, Marginal Zone 21Dendritic Cell Sarcoma, Interdigitating 20Multiple Myeloma 19Recurrence 18Myeloproliferative Disorders 18Graft vs Host Disease 18Blast Crisis 18Neoplasms, Plasma Cell 17Leukemia, Myelomonocytic, Chronic 16Leukemia, Biphenotypic, Acute 16Congenital Abnormalities 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, T-Cell, Cutaneous 13Primary Myelofibrosis 12Lymphoma, Large-Cell, Anaplastic 12

Interventions

Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ulcer × Methylprednisolone × Lymphoid × Clear all
NCT00676832 2010-09-29

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Prometheus Laboratories

Phase 2 Completed
190 enrolled
Lymphoid

Colitis, Colitis, Ulcerative, Lymphoma, Follicular, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡